Trademarkia Logo

Canada

C$
WEUPHORIA
REGISTERED

on 12 Oct 2022

Last Applicant/ Owned by

WALVAX BIOTECHNOLOGY CO.LTD.

4/F, Bldg. A3, Phase 2 Yunnan Universities Science & Technology Park,North Area, High & New Tech Development650000 Zone Kunming, Yunnan

CN

Serial Number

2053494 filed on 8th Jul 2020

Registration Number

TMA1145930 registered on 12th Oct 2022

Registration expiry Date

8th Jul 2030

Correspondent Address

NEOMARK LTD.

7450 rue Saint-HubertMontréal

QUEBEC

CA

H2R2N3

WEUPHORIA

Trademark usage description

bacteriological culture mediums; medicines and pharmaceutical preparations for the prevention and treatment of hpv (human papillomavirus) viral infect Read More

Classification Information


Class [005]
Bacteriological culture mediums; medicines and pharmaceutical preparations for the prevention and treatment of HPV (human papillomavirus) viral infection; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the prevention and treatment of HPV (human papillomavirus) viral infection; pharmaceutical preparations for the treatment and prevention of hiv infection; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; pharmaceuticals for the treatment of coronavirus diseases and COVID-19; human vaccines; veterinary vaccines; drugs for the treatment of pneumonia; drugs for anti-bacterial infection; antitumor drugs; biological fungicides for medical purposes; biological tissue cultures for medical purposes; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for use in immunotherapies; pre-filled syringes with pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; pre-filled syringes with pharmaceutical preparations for treating auto-immune diseases; lactose for pharmaceutical purposes; depuratives for the body; biological fungicides for veterinary purposes; biological tissue cultures for veterinary purposes; biocides.


Classification kind code

11

Mark Details


Serial Number

2053494

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 6th May 2022
Agent Changed
Submitted for opposition 22
on 11th Jan 2022
Search Recorded
Submitted for opposition 20
on 11th Jan 2022
Examiner's First Report
Submitted for opposition 223
on 11th Jan 2022
Total Provisional Refusal
Submitted for opposition 256
on 26th Jul 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 24th Sept 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 23rd Sept 2020
Created
Submitted for opposition 31
on 23rd Sept 2020
Formalized
Submitted for opposition 30
on 8th Jul 2020
Filed
Submitted for opposition 228
on 8th Jul 2020
International Registration